D-1568-2014 Class I Terminated
FDA drug recall D-1568-2014 was initiated by Pharmakon Pharmaceuticals on Apr 21, 2014 and is designated Class I. Reason for recall: Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol. The recall status is terminated (terminated Dec 3, 2014). Affected quantity: 5 Syringes.
Recall Details
- Product Type
- Drugs
- Report Date
- Sep 3, 2014
- Initiation Date
- Apr 21, 2014
- Termination Date
- Dec 3, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5 Syringes
Product Description
Atropine Sulfate 0.4 mg/ml Injection, USP, Total Dosage 0.8 mg per 2 mL, 3 mL pre-filled syringe, Rx Only. Pharmakon Pharmaceuticals, Inc., 14450 Getz Road, Noblesville, IN. NDC: 45183-0105-78.
Reason for Recall
Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.
Distribution Pattern
United States: TX, IL, MD, IN
Code Information
Lot #: E0333282R; Exp: 7/13/2014
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1568-2014
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 26, 2026